Pharmaceuticals

Rare Kidney Diseases Market Expansion Outlook: $4.41 Billion by 2029 Forecast

November 7, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Rare Kidney Diseases Market By 2029?

The rare kidney diseases market size has seen substantial growth over recent years. It is projected to expand from $2.76 billion in 2024 to reach $3.03 billion in 2025, at a compound annual growth rate (CAGR) of 9.6%. The historical growth of this market can be attributed to several factors, including heightened disease recognition, the granting of orphan drug designations, efforts in patient advocacy and awareness, and global research collaborations.

The market for rare kidney diseases is projected to experience substantial expansion in the coming years. This market is anticipated to reach “$4.41 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 9.8%. Key factors driving this growth during the forecast period include the advent of gene therapies, augmented investment in research for rare diseases, increased collaboration among various stakeholders, and worldwide initiatives targeting rare diseases. Significant trends expected within the forecast period encompass a patient-focused methodology, the use of real-world evidence and data analytics, evolving regulatory frameworks, the adoption of telemedicine and remote monitoring, and broader global health programs.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11908&type=smp

Which Drivers Are Impacting The Rare Kidney Diseases Market?

The rare kidney disease market’s expansion is expected to be driven by government initiatives and financial backing for kidney disorders. Government initiatives and funding constitute a type of official financial support provided to chosen organizations with ideas or projects that contribute to and enhance public services and the economy. The government offers aid for kidney disorders to bolster disease surveillance and improve the quality of life for individuals with various kidney ailments through a comprehensive public health strategy that involves other public health agencies and national organizations. For instance, in July 2022, The United States House Committee on Appropriations, a US-based committee of the House of Representatives, launched several investment programs to promote kidney health. This included $8.5 million in funding for the Centers for Disease Control and Prevention’s (CDC) chronic kidney disease program to accelerate efforts promoting consistent kidney disease awareness, diagnosis, and treatment. Additionally, a living donation investment of $1 million was made to strengthen the National Living Donor Assistance Center, bringing the total to $8 million in ongoing investment in innovation and research. Therefore, government initiatives and funding for kidney disorders are fueling the growth of the rare kidney disease market.

How Is The Rare Kidney Diseases Market Segmented?

The rare kidney diseases market covered in this report is segmented –

1) By Target Indication: IgA Nephropathy, Lupus Nephritis, Focal Segmental Glomerular Sclerosis, Membranous Nephropathy, C3 Glomerulopathy, Other Target Indications

2) By Type Of Molecule: Small Molecules, Biologics

3) By Route Of administration: Oral, Intravenous, Subcutaneous, Other Routes Of Administration

Subsegments:

1) By IgA Nephropathy: Immunosuppressive Therapy, Supportive Care And Symptomatic Management

2) By Lupus Nephritis: Corticosteroids, Antimalarial Agents, Biologics

3) By Focal Segmental Glomerular Sclerosis (FSGS): Corticosteroids, Angiotensin Receptor Blockers (ARBs), Other Immunosuppressive Agents

4) By Membranous Nephropathy: Corticosteroids, Immunosuppressive Therapy, Monoclonal Antibodies

5) By C3 Glomerulopathy: Complement Inhibitors, Supportive Care, Immunosuppressive Therapies

6) By Other Target Indications: Alport Syndrome, Thin Basement Membrane Nephropathy, Other Rare Kidney Disorders

Which Market Trends Are Creating New Opportunities In The Rare Kidney Diseases Industry?

Product innovation is a prominent trend gaining traction in the rare kidney disease market. Key market players are directing their efforts towards developing novel products to fortify their position. For example, in September 2022, STADA Arzneimittel AG, a Germany-based company engaged in generics, specialty pharma, and non-prescription consumer healthcare products, launched Kinpeygo (budesonide). This was the first medication authorized in the EU specifically for the treatment of rare kidney disease, immunoglobulin A nephropathy (IgAN). The modified-release budesonide capsules stand as the initial and exclusive approved treatment in the EU for primary IgAN, a rare, progressive autoimmune kidney disease associated with substantial unmet needs, where more than 25%-30% of patients eventually experience terminal kidney insufficiency, demanding dialysis or kidney transplantation.

Which Major Industry Participants Are Leading The Rare Kidney Diseases Market Growth?

Major companies operating in the rare kidney diseases market include Merck & Co. Inc., Novartis AG, Sanofi S.A, AstraZeneca plc, Otsuka Pharmaceutical Co Ltd., Alexion Pharmaceuticals Inc., Horizon Therapeutics plc., Recordati S.p.A., Amicus Therapeutics Inc., Akebia Therapeutics Inc., Travere Therapeutics, FibroGen Inc., Aurinia Pharmaceuticals Inc., Calliditas Therapeutics AB, Apellis Pharmaceuticals Inc., Protalix Biotherapeutics Inc., ChemoCentryx Inc., Omeros Corporation, Celtaxsys Inc., Corbus Pharmaceuticals Holdings Inc., Chinook Therapeutics Inc., OxThera AB, Advicenne Pharma SA, Reata Pharmaceuticals Inc., Savara Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/rare-kidney-diseases-global-market-report

How Is Rare Kidney Diseases Market Demand Varying Across Different Regions?

North America was the leading region in the rare kidney disease market in 2024. The regions covered in the rare kidney diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Rare Kidney Diseases Market Report:

https://www.thebusinessresearchcompany.com/customise?id=11908&type=smp

Browse Through More Reports Similar to the Global Rare Kidney Diseases Market 2025, By The Business Research Company

Veterinary Anti Infectives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

Animal Antibiotics And Antimicrobials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/animal-antibiotics-and-antimicrobials-global-market-report

Veterinary Antibiotics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795